Exposure to air pollutants, even at very low concentrations, was associated with adverse changes in cardiometabolic risk factors in a recent Finnish study
NVIDIA doubles down on AI in healthcare with drug discovery deals – Pharmaceutical Technology
Share this article Concurrent with the partnerships, NVIDIA also released a new suite of healthcare microservices that includes a collection of models for drug discovery